Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 4:01 pm Purchase | 2024-10-15 | 13D | MorphoSys AG MOR | NOVARTIS AG | 37,716,423 100.000% | 2,108,003 (+5.92%) | Filing History |
| 2024-08-15 4:30 pm Purchase | 2024-08-13 | 13D | MorphoSys AG MOR | NOVARTIS AG | 35,608,420 94.550% | 1,270,611 (+3.70%) | Filing History |
| 2024-06-21 4:30 pm Unchanged | 2024-06-19 | 13D | MorphoSys AG MOR | NOVARTIS AG | 34,337,809 91.170% | 0 (Unchanged) | Filing History |
| 2024-06-17 4:30 pm Purchase | 2024-06-16 | 13D | MorphoSys AG MOR | NOVARTIS AG | 34,337,809 91.170% | 641,331 (+1.90%) | Filing History |
| 2024-06-10 4:30 pm Purchase | 2024-06-06 | 13D | MorphoSys AG MOR | NOVARTIS AG | 33,696,478 89.470% | 3,725,565 (+12.43%) | Filing History |
| 2024-06-10 12:06 pm Sale | 2024-05-31 | 13G | MorphoSys AG MOR | GOLDMAN SACHS GROUP INC GS | 1,084,624 2.900% | -3,056,465 (-73.81%) | Filing History |
| 2024-05-28 4:30 pm Purchase | 2024-05-23 | 13D | MorphoSys AG MOR | NOVARTIS AG | 29,970,913 79.580% | 25,610,813 (+587.39%) | Filing History |
| 2024-04-18 2:33 pm Purchase | 2024-04-12 | 13D | MorphoSys AG MOR | NOVARTIS AG | 4,360,100 11.560% | 4,360,100 (New Position) | Filing History |
| 2024-03-11 4:36 pm Purchase | 2024-02-29 | 13G | MorphoSys AG MOR | GOLDMAN SACHS GROUP INC GS | 4,141,089 10.800% | 4,141,089 (New Position) | Filing History |
| 2024-03-08 3:58 pm Purchase | 2024-02-29 | 13G | MorphoSys AG MOR | Kynam Capital Management, LP | 4,190,331 11.130% | 500,000 (+13.55%) | Filing History |
| 2024-02-16 4:57 pm Sale | 2023-12-31 | 13G | MorphoSys AG MOR | T. Rowe Price Investment Management, Inc. | 6,431,063 4.300% | -2,712,552 (-29.67%) | Filing History |
| 2024-02-14 12:47 pm Purchase | 2023-12-31 | 13G | MorphoSys AG MOR | Kynam Capital Management, LP | 3,690,331 9.800% | 3,690,331 (New Position) | Filing History |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | MorphoSys AG MOR | T. Rowe Price Investment Management, Inc. | 9,143,615 4.300% | 1,865,517 (+25.63%) | Filing History |
| 2023-02-14 12:40 pm Purchase | 2022-12-31 | 13G | MorphoSys AG MOR | T. Rowe Price Investment Management, Inc. | 7,278,098 5.300% | 7,278,098 (New Position) | Filing History |
| 2021-02-08 10:27 am Sale | 2021-02-05 | 13G | MorphoSys AG MOR | FMR LLC | 118,545 0.360% | -2,990,704 (-96.19%) | Filing History |
| 2020-10-09 09:14 am Sale | 2020-09-30 | 13G | MorphoSys AG MOR | BlackRock Inc. BLK | 1,636,430 4.970% | -937,979 (-36.43%) | Filing |